Ibiden Co.,Ltd.
IBIDF · OTC
3/31/2025 | 3/31/2024 | 3/31/2023 | 3/31/2022 | |
|---|---|---|---|---|
| Revenue | $369,436,000 | $370,511,000 | $417,549,000 | $401,138,000 |
| % Growth | -0.3% | -11.3% | 4.1% | – |
| Cost of Goods Sold | $256,108,000 | $268,040,000 | $290,033,000 | $281,059,000 |
| Gross Profit | $113,328,000 | $102,471,000 | $127,516,000 | $120,079,000 |
| % Margin | 30.7% | 27.7% | 30.5% | 29.9% |
| R&D Expenses | $182,988 | $20,229,000 | $19,682,000 | $15,733,000 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $65,706,000 | $34,673,000 | $35,470,000 | $33,525,000 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | -$181,988 | $1,000 | $0 | $0 |
| Operating Expenses | $65,707,000 | $54,903,000 | $55,152,000 | $49,258,000 |
| Operating Income | $47,621,000 | $47,568,000 | $72,362,000 | $70,821,000 |
| % Margin | 12.9% | 12.8% | 17.3% | 17.7% |
| Other Income/Exp. Net | $3,830,000 | -$133,000 | -$660,000 | -$11,569,000 |
| Pre-Tax Income | $51,451,000 | $47,435,000 | $71,702,000 | $59,252,000 |
| Tax Expense | $17,400,000 | $15,685,000 | $19,288,000 | $17,688,000 |
| Net Income | $33,704,000 | $31,490,000 | $52,187,000 | $41,232,000 |
| % Margin | 9.1% | 8.5% | 12.5% | 10.3% |
| EPS | 241.32 | 225.44 | 373.73 | 295.34 |
| % Growth | 7% | -39.7% | 26.5% | – |
| EPS Diluted | 226.19 | 224.86 | 373.73 | 295.34 |
| Weighted Avg Shares Out | 139,665 | 139,682 | 139,637 | 139,608 |
| Weighted Avg Shares Out Dil | 149,007 | 140,044 | 139,637 | 139,608 |
| Supplemental Information | – | – | – | – |
| Interest Income | $14,599 | $8,140 | $7,188 | $846 |
| Interest Expense | $8,706 | $5,556 | $4,268 | $3,491 |
| Depreciation & Amortization | $54,205,000 | $46,032,000 | $55,014,000 | $52,807,000 |
| EBITDA | $106,811,000 | $94,177,000 | $127,278,000 | $112,339,000 |
| % Margin | 28.9% | 25.4% | 30.5% | 28% |